Holen Sie sich die Stockscreener-App
40.10
2.48%
0.97
Schlusskurs vom Vortag:
$39.13
Offen:
$40
24-Stunden-Volumen:
1.60M
Relative Volume:
0.73
Marktkapitalisierung:
$8.27B
Einnahmen:
$2.10B
Nettoeinkommen (Verlust:
$402.17M
KGV:
20.72
EPS:
1.9357
Netto-Cashflow:
$403.87M
1W Leistung:
+2.98%
1M Leistung:
+12.36%
6M Leistung:
-11.26%
1J Leistung:
-17.56%
1-Tages-Spanne:
$39.75
$40.18
1-Wochen-Bereich:
$38.63
$40.18
52-Wochen-Spanne:
$32.53
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Compare QGEN vs TMO, DHR, IDXX, NTRA, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
40.10 | 8.06B | 2.10B | 402.17M | 403.87M | 1.9357 |
TMO
Thermo Fisher Scientific Inc
|
523.44 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
197.93 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.80 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
279.32 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
379.29 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-03-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-22 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Qiagen N.V. highlights digital PCR expansion. Stock trades near recent highs on Nasdaq - AD HOC NEWS
Qiagen earnings calendar and diagnostics pipeline, shares watched by international investors - AD HOC NEWS
Qiagen earnings calendar stands out this week, shares steady on Xetra - AD HOC NEWS
Qiagen steady ahead of earnings, shares watched by analysts - AD HOC NEWS
QIAGEN NV Actuals & Estimates (TURQUOISE:QIAD) - TradingView
The QIAamp DNA Mini Kit from Qiagen N.V.quiet lab workhorse for clean samples - AD HOC NEWS
Qiagen N.V.(NYSE: QGEN) added to Russell 1000 Dynamic Index - marketscreener.com
Qiagen consistent with diagnostics strategy, shares follow sector trend - AD HOC NEWS
QIAGEN NV Actuals & Estimates (AQUISUK:QIAD) - TradingView
Qiagen expands QIAcuity gene expression tools, shares remain muted on NYSE - AD HOC NEWS
QIAGEN NV Actuals & Estimates (VIE:QGE4) - TradingView
Qiagen N.V. refines diagnostics portfolio, shares backed by long-term strategy - AD HOC NEWS
Qiagen steadies after recent pullback, shares tracked on NYSE and Xetra - Ad-hoc-news.de
Enterprise value to EBIT forward of Qiagen N.V. – NYSE:QGEN - TradingView
Qiagen updates its diagnostics focus, shares anchored in health-care demand - AD HOC NEWS
QGEN Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Qiagen N.V. – NYSE:QGEN - TradingView
Qiagen earnings calendar and diagnostics outlook, shares in focus for Nasdaq investors - AD HOC NEWS
Qiagen extends its recent high, shares near 52-week peak on NYSE and Xetra - AD HOC NEWS
Bloodstream Infection Testing Market Size to Reach USD 1,404.68 Million by 2035 | SNS Insider - GlobeNewswire Inc.
QIAGEN NV Actuals & Estimates (BIVA:QIA/N) - TradingView
Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers - AD HOC NEWS
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen adjusts portfolio in Europe, shares track diagnostics peers - Ad-hoc-news.de
QIAGEN NV Actuals & Estimates (NYSE:QGEN) - TradingView
Qiagen publishes new sustainability report, shares backed by fresh analyst support - Ad-hoc-news.de
Enterprise value to EBITDA forward of Qiagen N.V. – NYSE:QGEN - TradingView
Kepler Cheuvreux Initiates Qiagen Coverage at Hold - marketscreener.com
Is Qiagen's (QGEN) Digital PCR Expansion Quietly Redefining Its Competitive Moat in Biopharma Tools? - simplywall.st
Qiagen N : Sustainability Report (ca ab 1305 voluntary carbon market disclosure 2026) - marketscreener.com
Qiagen N : Sustainability Report (ca ab 1305 voluntary carbon market disclosure) - marketscreener.com
Qiagen NV Annual Shareholders Meeting Transcript - GuruFocus
Qiagen (QGEN) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Morgan Stanley Upgrades Qiagen to Overweight, Raises PT - marketscreener.com
QGEN Upgraded by Morgan Stanley -- Price Target Raised to $42.00 - GuruFocus
Barclays Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $38 - Moomoo
Qiagen annual meeting in Venlo, shares under DAX investor scrutiny - Ad-hoc-news.de
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen updates draw analyst attention, shares react on NYSE and Xetra - Ad-hoc-news.de
Qiagen Raised to Overweight From Equal-Weight by Morgan Stanley - Moomoo
Qiagen gets a DZ Bank lift, analyst consensus shapes the shares - Ad-hoc-news.de
QIAGEN NV : Gets a Buy rating from DZ Bank - marketscreener.com
Qiagen NV (QGEN) Institutional Confidence - TradingKey
Morgan Stanley Upgrades Qiagen NV(QGEN.US) to Buy Rating, Raises Target Price to $42 - Moomoo
Qiagen strategy and digital PCR expansion, shares tracked on Xetra and NYSE - AD HOC NEWS
Qiagen NV: QIAGEN N.V.Share Consolidation/Cash Distribution Option Symbol: QGEN New Symbol: QGEN1 - Moomoo
Qiagen Stockweekly outlook with earnings ahead - AD HOC NEWS
Qiagen NV (QGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Goldman Sachs Reports 2.87% Stake in Qiagen via Equity and Derivatives - The Globe and Mail
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):